Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.03 +0.01 (+0.74%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Other Non-Current Assets (2021 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) reported Other Non-Current Assets of $263,000 for Q2 2026, down 43.3% from $464,000 a year earlier and down 13.5% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Other Non-Current Assets (2021 - 2026) Analysis & Trends

At the end of FY2025, Acumen Pharmaceuticals posted Other Non-Current Assets of $350,000, down 28.0% from FY2024.

  • Other Non-Current Assets has a four-year compound annual growth rate of 123.6% (FY2021 to FY2025).
  • By year, Other Non-Current Assets came in at $486,000 in FY2024 (-32.9%), $724,000 in FY2023 (+379.5%), $151,000 in FY2022 (+978.6%) and $14,000 in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Assets since Q3 2024.
  • Year over year, Other Non-Current Assets has now declined in each of the last three quarters, with growth averaging 1.5% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Assets in five years was Q4 2022 (growth of 978.6%); the low point was Q2 2022 (a decline of 89.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $304,000 (Q1 2026), $350,000 (Q4 2025) and $393,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Acumen Pharmaceuticals 147.03 Mn -335.04 Mn - 725,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 725,000.00
Mar 31, 2026 766,000.00
Dec 31, 2025 812,000.00
Sep 30, 2025 857,000.00
Jun 30, 2025 464,000.00
Mar 31, 2025 968,000.00
Dec 31, 2024 950,000.00
Sep 30, 2024 642,000.00
Jun 30, 2024 895,000.00
Mar 31, 2024 792,000.00
Dec 31, 2023 957,000.00
Sep 30, 2023 189,000.00
Jun 30, 2023 391,000.00
Mar 31, 2023 195,000.00
Dec 31, 2022 151,000.00
Jun 30, 2022 344,000.00
Mar 31, 2022 79,000.00
Dec 31, 2021 14,000.00
Sep 30, 2021 13,000.00
Jun 30, 2021 2.37 Mn
API Access

Acumen Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABOS&period=max&api_key=YOUR_API_KEY